Dickkopf 1 and Neuregulin 1 as cutaneous biomarkers for dermal pigmentation activity in acquired dermal macular hyperpigmentation (ADMH): a case control study
Archives of Dermatological Research · 2025
DOI: 10.1007/s00403-025-03906-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Dermatological Research, 2025. Verfasst von Abhay Gupta und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012, India. Hauptthemen laut MEDLINE: Neuregulin-1, Intercellular Signaling Peptides and Proteins, Hyperpigmentation, Skin Pigmentation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Lichen planus pigmentosus (LPP), ashy dermatosis, and Riehl's melanosis are all referred to by the general term acquired dermal macular hyperpigmentation (ADMH). These conditions are distinguished clinically by hyperpigmented macules and patches of unknown cause. Melanogenesisis regulated by multiple dermal factors secreted by fibroblasts and among them are neuregulin1 (NRG1) and dickkopf1 (DKK1). This study was designed to study NRG1 and DKK1 as cutaneous biomarkers for activity of dermal pigmentation in ADMH and to correlate their activity with acquired dermal macular hyperpigmentation area and severity index (DPASI) score. A total of 35 clinically diagnosed ADMH patients and 10 healthy controls along with 4 positive controls of melasma patients were included in the study and DPASI score was calculated using Dermlite (DL4) dermatoscope to assess the disease severity. Skin biopsy samples were taken and immunofluorescence and qPCR were performed to measure the expression of NRG1 and DKK1. A correlation of NRG1 expression, DKK1 expression with DPASI score was assessed. NRG1 expression had a linear positive correlation with DPASI score with a correlation coefficient (r = 0.97) (p < 0.001), while DKK1 showed an inverse correlation with a correlation coefficient (r=-0.69) (p < 0.001). NRG1 and DKK1 expression regulates pigmentation in ADMH and they can be used as an objective tool to assess the disease activity and probably guide therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012, India.
- Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012, India. parsad@me.com.
Zitieren
APA
Gupta, A., Sharma, A., Kumar, V., Kaushal, L., Vinay, K., Kumaran, M. S., Bishnoi, A., & Parsad, D. (2025). Dickkopf 1 and Neuregulin 1 as cutaneous biomarkers for dermal pigmentation activity in acquired dermal macular hyperpigmentation (ADMH): a case control study. Archives of Dermatological Research. https://doi.org/10.1007/s00403-025-03906-8
Vancouver
Gupta A, Sharma A, Kumar V, Kaushal L, Vinay K, Kumaran MS, et al. Dickkopf 1 and Neuregulin 1 as cutaneous biomarkers for dermal pigmentation activity in acquired dermal macular hyperpigmentation (ADMH): a case control study. Archives of Dermatological Research. 2025. doi:10.1007/s00403-025-03906-8
BibTeX
@article{Gupta2025,
author = {Gupta, Abhay and Sharma, Apoorva and Kumar, Vinod and Kaushal, Laveena and Vinay, Keshavamurthy and Kumaran, Muthu Sendhil and Bishnoi, Anuradha and Parsad, Davinder},
title = {Dickkopf 1 and Neuregulin 1 as cutaneous biomarkers for dermal pigmentation activity in acquired dermal macular hyperpigmentation (ADMH): a case control study},
journal = {Archives of Dermatological Research},
year = {2025},
doi = {10.1007/s00403-025-03906-8}
}
EUVIMED